litlas
Log inCreate account

Paolo Bruzzi

Active 1985–2023

112
Papers
20,202
Citations
85
h-index
112
i10-index

Citations

Citations per year for Paolo Bruzzi1982: 3 citations1984: 1 citations1986: 1 citations1987: 1 citations1988: 4 citations1989: 9 citations1990: 15 citations1991: 15 citations1992: 13 citations1993: 17 citations1994: 19 citations1995: 23 citations1996: 29 citations1997: 41 citations1998: 42 citations1999: 52 citations2000: 58 citations2001: 67 citations2002: 59 citations2003: 85 citations2004: 85 citations2005: 79 citations2006: 112 citations2007: 99 citations2008: 143 citations2009: 162 citations2010: 175 citations2011: 173 citations2012: 159 citations2013: 157 citations2014: 144 citations2015: 153 citations2016: 144 citations2017: 146 citations2018: 118 citations2019: 460 citations2020: 471 citations2021: 602 citations2022: 385 citations2023: 235 citations2024: 379 citations2025: 154 citations2026: 2 citations1983: no citations, so this year is not shown1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,960 citing papers, 20.5% of this breakdownItaly: 983 citing papers, 10.3% of this breakdownUnited Kingdom: 771 citing papers, 8.1% of this breakdownGermany: 549 citing papers, 5.7% of this breakdownFrance: 469 citing papers, 4.9% of this breakdownChina: 443 citing papers, 4.6% of this breakdownCanada: 375 citing papers, 3.9% of this breakdownNetherlands: 362 citing papers, 3.8% of this breakdownSpain: 338 citing papers, 3.5% of this breakdownAustralia: 280 citing papers, 2.9% of this breakdownSwitzerland: 243 citing papers, 2.5% of this breakdownBelgium: 228 citing papers, 2.4% of this breakdown
0%20.5%Other 26.9%

Institutions

Fields

  • Medicine76%
  • Biochemistry, Genetics and Molecular Biology16%
  • Immunology and Microbiology2%
  • Health Professions1.5%
  • Mathematics0.7%
  • Engineering0.4%
  • Other3.4%

Topics

  • Breast Cancer Treatment Studies3.2%
  • Cardiomyopathy and Myosin Studies3%
  • COVID-19 Clinical Research Studies1.9%
  • Multiple Sclerosis Research Studies1.7%
  • Sarcoma Diagnosis and Treatment1.7%
  • Cancer Risks and Factors1.7%
  • Other86.8%

Coauthors

All papers

Open in search
  1. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Authors: Richard J. Gray, Rosie Bradley, Jeremy Braybrooke, Zulian Liu, Richárd Pető, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn Taylor, William E. Barlow, Judith M. Bliss, Paolo Bruzzi, David Cameron, George Fountzilas, Sibylle Loibl, John R. Mackey, Miguel Martín, Lucia Del Mastro, Volker Möbus, Valentina Nekljudova, Sabino De Placido, Sandra M. Swain, Michael Untch, Kathleen I. Pritchard, Jonas Bergh, Larry Norton, Clare Boddington, Julie Ann Burrett, Mike Clarke, Christina Davies, Frances Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert K. Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter A. Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther G. Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, J.-M. Nogaret, C. Philippson, Martine Piccart, Sabine C. Linn, Petronella G.M. Peer, Vivianne C. G. Tjan‐Heijnen, S.B. Vliek, John R. Mackey, Dennis Slamon, John M.S. Bartlett, Vivien Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Joseph L. Pater, Eileen Rakovitch, Lois E. Shepherd, Dongsheng Tu, Timothy J. Whelan, Donald A. Berry, Gloria Broadwater, Constance Cirrincione, Hyman B. Muss, Raymond L. Weiss, Yi Shan, Yong fu Shao, Xiang Wang, Binghe Xu, Dongbing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fátima Cardoso, Tanja Čufer, Jean‐Pierre Julien, Philip Poortmans, Emiel J. Rutgers, Cornelis J.�H. van de Velde, Eva Carrasco, Miguel Ángel Seguí, Jens‐Uwe Blohmer, Serban Dan Costa, Bernd Gerber and 67 more - The Lancet 2019 cited by 394

  2. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

    Authors: Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Antonella Brunello, Jean‐Yves Blay, Oscar Tendero, Robert Díaz Beveridge, Virginia Ferraresi, Iwona Ługowska, Domenico Franco Merlo, Valeria Fontana, Emanuela Marchesi, Luca Braglia, Davide María Donati, Elena Palassini, Giuseppe Bianchi, Andrea Marrari, Carlo Morosi, Silvia Stacchiotti, Sílvia Bagué, Jean Michel Coindre, Angelo Paolo Dei Tos, Piero Picci, Paolo Bruzzi, Paolo G. Casali - Journal of Clinical Oncology 2020 cited by 261

  3. Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial

    Authors: Corrado Tinterri, Damiano Gentile, Wolfgang Gatzemeier, Andrea Sagona, E. Barbieri, Alberto Testori, Valentina Errico, Alberto Bottini, Emilia Marrazzo, Carla Dani, Béatrice Dozin, Luca Boni, Paolo Bruzzi, Bethania Fernandes, Davide Franceschini, Ruggero Spoto, Rosalba Torrisi, Marta Scorsetti, Armando Santoro, Giuseppe Canavese, the SINODAR-ONE Collaborative Group, Olindo Custodero, Vito Leopoldo Troilo, Mario Taffurelli, M.C. Cucchi, V. Galluzzo, Carlo Cabula, Roberta Cabula, Maria Grazia Lazzaretti, Francesco Caruso, Gaetano Castiglione, Simona Grossi, Maria Saveria Tavoletta, Camilla De Rossi, Annalisa Curcio, Daniele Friedman, Piero Fregatti, Carla Magni, Giovanni Tazzioli, Simona Papi, Riccardo Giovanazzi, Camelia Chifu, Rossella Bettini, Modestino Pezzella, Silvia Michieletto, Tania Saibene, Manuela Roncella, Matteo Ghilli, Andrea Sibilio, Anna Cariello, Saverio Coiro, Giuseppe Falco, Emanuele Zarba Meli, Lucio Fortunato, L. Ciuffreda, Roberto Murgo, Claudio Battaglia, Luca Rubino, Nicoletta Biglia, Valentina Elisabetta Bounous, Francesca Rovera, Corrado Chiappa, Giovanni Paolo Pollini, Sara Mirandola, Graziano Meneghini, Francesco Di Bartolo - Annals of Surgical Oncology 2022 cited by 154

  4. Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment

    Authors: Corrado Tinterri, Giuseppe Canavese, Wolfgang Gatzemeier, E. Barbieri, Alberto Bottini, Andrea Sagona, Giulia Caraceni, Alberto Testori, Simone Di Maria Grimaldi, Carla Dani, Luca Boni, Paolo Bruzzi, Bethania Fernandes, Marta Scorsetti, Alberto Zambelli, Damiano Gentile, SINODAR-ONE Collaborative Group, Massimo Maria Grassi, Olindo Custodero, Vito Leopoldo Troilo, Mario Taffurelli, M.C. Cucchi, V. Galluzzo, Carlo Cabula, Roberta Cabula, Maria Grazia Lazzaretti, Francesco Caruso, Gaetano Castiglione, Simona Grossi, Maria Saveria Tavoletta, Camilla De Rossi, Annalisa Curcio, Daniele Friedman, Piero Fregatti, Carla Magni, Giovanni Tazzioli, Simona Papi, Riccardo Giovanazzi, Camelia Chifu, Rossella Bettini, Modestino Pezzella, Silvia Michieletto, Tania Saibene, Manuela Roncella, Matteo Ghilli, Andrea Sibilio, Anna Cariello, Saverio Coiro, Giuseppe Falco, Emanuele Zarba Meli, Lucio Fortunato, L. Ciuffreda, Roberto Murgo, Claudio Battaglia, Luca Rubino, Nicoletta Biglia, Valentina Elisabetta Bounous, Francesca Rovera, Corrado Chiappa, Giovanni Paolo Pollini, Sara Mirandola, Graziano Meneghini, Francesco Di Bartolo, Oreste ­Gentilini - British journal of surgery 2023 cited by 57

  5. Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy

    Authors: Paolo Spirito, Pietro Bellone, Kevin M. Harris, Paola Bernabò, Paolo Bruzzi, Barry J. Maron - New England Journal of Medicine 2000 cited by 1,139

  6. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

    Authors: Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Umberto Basso, Jean‐Yves Blay, Oscar Tendero, Robert Díaz Beveridge, Virginia Ferraresi, Iwona Ługowska, Domenico Franco Merlo, Valeria Fontana, Emanuela Marchesi, Davide María Donati, Elena Palassini, Emanuela Palmerini, Rita De Sanctis, Carlo Morosi, Silvia Stacchiotti, Sílvia Bagué, J.M. Coindre, Angelo Paolo Dei Tos, Piero Picci, Paolo Bruzzi, Paolo G. Casali - The Lancet Oncology 2017 cited by 489

  7. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

    Authors: Silvia Stacchiotti, Alessandro Gronchi, P Fossati, T. Akiyama, C. Alapetite, Michaël Baumann, Jean‐Yves Blay, Stéphanie Bolle, Stefano Boriani, Paolo Bruzzi, Rodolfo Capanna, Augusto Caraceni, R. Casadei, Vittoria Colia, J. Debus, Thomas F. DeLaney, Atman Desai, Palma Dileo, P. D. S. Dijkstra, Francesco Doglietto, Adrienne M. Flanagan, Sébastien Froelich, Paul A. Gardner, Hans Gelderblom, Z. Gokaslan, Rick L. Haas, C. Heery, Nadia Hindi, P. Hohenberger, Francis J. Hornicek, Reiko Imai, Lee Jeys, Robin L. Jones, Bernd Kasper, Akira Kawai, Marco Krengli, A. Leithner, I. Logowska, Javier Martín‐Broto, Diego Mazzatenta, Carlo Morosi, P. Nicolai, O.J. Norum, Shreyaskumar Patel, Nicolas Penel, Piero Picci, S. Pilotti, Stefano Redaelli, F. Ricchini, Piotr Rutkowski, S. Scheipl, Chandranath Sen, E. Tamborini, Katherine A. Thornton, Beate Timmermann, Valter Torri, P.-U. Tunn, M. Uhl, Yoshiya Yamada, Damien C. Weber, D. Vanel, Péter Varga, Carmen Vleggeert‐Lankamp, Paolo G. Casali, J. Sommer - Annals of Oncology 2017 cited by 243

  8. Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial

    Authors: Lucia Del Mastro, Mauro Mansutti, Giancarlo Bisagni, Riccardo Ponzone, Antonio Durando, Laura Amaducci, Enrico Campadelli, F. Cognetti, Antonio Frassoldati, Andrea Michelotti, Silvia Mura, Ylenia Urracci, Giovanni Sanna, Stefania Gori, Sabino De Placido, Ornella Garrone, Alessandra Fabi, C. Barone, Stefano Tamberi, Claudia Bighin, Fabio Puglisi, Gabriella Moretti, Grazia Arpino, Alberto Ballestrero, Francesca Poggio, Matteo Lambertini, Filippo Montemurro, Paolo Bruzzi - The Lancet Oncology 2021 cited by 86

  9. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

    Authors: Małgorzata Mikulska, Diana Averbuch, Frédéric Tissot, Catherine Cordonnier, Murat Akova, Thierry Calandra, Marcello Ceppi, Paolo Bruzzi, Claudio Viscoli, Murat Akova, Mahmoud Aljurf, Diana Averbuch, Rosemary A. Barnes, Ola Blennow, Pierre–Yves Bochud, Emilio Bouza, Stéphane Bretagne, Roger J. M. Brüggemann, Thierry Calandra, Jordi Carratalà, Simone Cesaro, Catherine Cordonnier, Oliver A. Cornely, Tina Dalianis, Rafael de la Cámara, Peter Donnelly, Ľuboš Drgoňa, Rafael F. Duarte, Hermann Einsele, Dan Engelhard, Christopher P. Fox, Corrado Girmenia, Andreas H. Groll, Dag Heldal, Jannick Helweg Larsen, Raoul Herbrecht, Hans H. Hirsch, Elisabeth Johnson, G. A. Klyasova, Minna Koskuenvo, Katrien Lagrou, Russell E. Lewis, Per Ljungman, Johan Maertens, Georg Maschmeyer, Małgorzata Mikulska, Márcio Nucci, Christophe Padoin, Livio Pagano, Antonio Pagliuca, Zdeněk Ráčil, Patricia Ribaud, Christine Rinaldo, Valérie Rizzi Puechal, Emmanuel Roilides, Christine Robin, Montserrat Rovira, Markus Rupp, Sonia P. Sanchez, Peter Schellongowski, Petr Sedlacek, János Sinkó, Monica A. Slavin, Isabella Sousa Ferreira, Jan Styczyński, Frédéric Tissot, Claudio Viscoli, Katherine N. Ward, Anne‐Therese Witschi - Journal of Infection 2017 cited by 196

  10. Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies

    Authors: Alfredo Berruti, Vito Amoroso, Fabio Gallo, Valentina Bertaglia, Edda Simoncini, Rebecca Pedersini, Laura Ferrari, Alberto Bottini, Paolo Bruzzi, Maria Pia Sormani - Journal of Clinical Oncology 2014 cited by 242

  11. Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

    Authors: Sandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Antonella Brunello, Jean‐Yves Blay, Oscar Tendero, Robert Díaz Beveridge, Virginia Ferraresi, Iwona Ługowska, Gabriele Infante, Luca Braglia, Domenico Franco Merlo, Valeria Fontana, Emanuela Marchesi, Davide María Donati, Elena Palassini, Giuseppe Bianchi, Andrea Marrari, Carlo Morosi, Silvia Stacchiotti, Sílvia Bagué, Jean Michel Coindre, Angelo Paolo Dei Tos, Piero Picci, Paolo Bruzzi, Rosalba Miceli, Paolo G. Casali, Alessandro Gronchi - Cancer 2021 cited by 101

  12. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia

    Authors: Carlo Salvarani, Giovanni Dolci, Marco Massari, Domenico Franco Merlo, Silvio Cavuto, Luisa Savoldi, Paolo Bruzzi, Fabrizio Boni, Luca Braglia, Caterina Turrà, Pier Ferruccio Ballerini, Roberto Sciascia, Lorenzo Zammarchi, Ombretta Para, Pier Giorgio Scotton, Walter O Inojosa, Viviana Ravagnani, Nicola Duccio Salerno, Pier Paolo Sainaghi, A Brignone, Mauro Codeluppi, Elisabetta Teopompi, Maurizio Milesi, P. Bertomoro, Claudio Norbiato, Mario Salio, Marco Falcone, Giovanni Cenderello, Lorenzo Donghi, Valerio Del Bono, Paolo Luigi Colombelli, Andrea Angheben, Angelina Passaro, G Secondo, Renato Pascale, Ilaria Piazza, Nicola Facciolongo, Massimo Costantini, RCT-TCZ-COVID-19 Study Group - JAMA Internal Medicine 2020 cited by 733

  13. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

    Authors: Fabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, Attilio Bondanza, Catia Traversari, Monica Salomoni, Lucia Turchetto, Scialini Colombi, Massimo Bernardi, Jacopo Peccatori, Alessandra Pescarollo, Paolo Servida, Zulma Magnani, Serena Perna, Veronica Valtolina, Fulvio Crippa, Luciano Callegaro, Elena Spoldi, Roberto Crocchiolo, Katharina Fleischhauer, Maurilio Ponzoni, Luca Vago, Silvano Rossini, Armando Santoro, Elisabetta Todisco, Jane F. Apperley, Eduardo Olavarría, Shimon Slavin, Eva M. Weissinger, Arnold Ganser, Michael Stadler, Evangelia Yannaki, Αthanasios Fassas, Αchilles Anagnostopoulos, Marco Bregni, Corrado Gallo Stampino, Paolo Bruzzi, Claudio Bordignon - The Lancet Oncology 2009 cited by 484

  14. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study

    Authors: Massimo Terzolo, Martin Faßnacht, Paola Perotti, Rossella Libé, Darko Kaštelan, André Lacroix, Wiebke Arlt, Harm R. Haak, Paola Loli, Bénédicte Decoudier, Hélène Lasolle, Marcus Quinkler, Magalie Haissaguerre, Olivier Chabre, Philippe Caron, Antonio Stigliano, Roberta Giordano, Maria Chiara Zatelli, Irina Bancos, Maria Candida Barisson Villares Fragoso, Letizia Canu, Michaela Luconi, Soraya Puglisi, Vittoria Basile, Giuseppe Reimondo, Matthias Kroiß, Felix Megerle, Stefanie Hahner, Otilia Kimpel, Tina Dušek, Svenja Nölting, Isabelle Bourdeau, Vasileios Chortis, Madeleine H. T. Ettaieb, Deborah Cosentini, Salvatore Grisanti, Eric Baudin, Paola Berchialla, Francesca Bovis, Maria Pia Sormani, Paolo Bruzzi, Felix Beuschlein, Jérôme Bertherat, Alfredo Berruti - The Lancet Diabetes & Endocrinology 2023 cited by 75

  15. Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy

    Authors: Paolo Spirito, Camillo Autore, Claudio Rapezzi, Paola Bernabò, Roberto Badagliacca, Martin S. Maron, Sergio Bongioanni, Fabio Coccolo, N.A. Mark Estes, Caterina Stella Barillà, Elena Biagini, Giovanni Quarta, Maria Rosa Conte, Paolo Bruzzi, Barry J. Maron - Circulation 2009 cited by 366

  16. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms

    Authors: Camillo Autore, Paola Bernabò, Caterina Stella Barillà, Paolo Bruzzi, Paolo Spirito - Journal of the American College of Cardiology 2005 cited by 263

  17. A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer

    Authors: Giovanni Battista Ratto, Paolo Zino, Sandro Mirabelli, Paolo Minuti, Riccardo Aquilina, G. Fantino, Elisabetta Spessa, Marco Ponte, Paolo Bruzzi, Giovanni Melioli - Cancer 1996 cited by 122

  18. A new prognostic and predictive tool for shared decision making in stage III colon cancer

    Authors: Alberto Sobrero, Alberto Puccini, Qian Shi, Axel Grothey, Thierry André, Anthony F. Shields, Ioannis Souglakos, Takayuki Yoshino, Timothy Iveson, Marcello Ceppi, Paolo Bruzzi - European Journal of Cancer 2020 cited by 69

  19. Risk associated with pregnancy in hypertrophic cardiomyopathy

    Authors: Camillo Autore, Maria Rosa Conte, Marco Piccininno, Paola Bernabò, G Bonfiglio, Paolo Bruzzi, Paolo Spirito - Journal of the American College of Cardiology 2002 cited by 198

  20. Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

    Authors: Barry J. Maron, Paolo Spirito, Win-Kuang Shen, Tammy S. Haas, Francesco Formisano, Mark S. Link, Andrew E. Epstein, Adrian K. Almquist, James P. Daubert, Thorsten Lawrenz, Giuseppe Boriani, N.A. Mark Estes, Stefano Favale, Marco Piccininno, Stephen L. Winters, Massimo Santini, Sandro Betocchi, Fernando Arribas, Mark V. Sherrid, Gianfranco Buja, Christopher Semsarian, Paolo Bruzzi - JAMA 2007 cited by 800

  21. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

    Authors: Andrea Bacigalupo, Teresa Lamparelli, Paolo Bruzzi, Stefano Guidi, P Alessandrino, Paolo Di Bartolomeo, Rosa Oneto, Barbara Bruno, M. Barbanti, Nicoletta Sacchi, Maria Teresa Van Lint, Alberto Bosi, for Gruppo Italiano Trapianti Midollo Osseo (GITMO) - Blood 2001 cited by 524

  22. Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

    Authors: Lucia Del Mastro, Sabino De Placido, Paolo Bruzzi, Michele De Laurentiis, C. Boni, Giovanna Cavazzini, Antonio Durando, Anna Turletti, Cecilia Nisticò, Enrichetta Valle, Ornella Garrone, Fabio Puglisi, Filippo Montemurro, Sandro Barni, Andrea Ardizzoni, Teresa Gamucci, Giuseppe Colantuoni, Mario Giuliano, Adriano Gravina, Paola Papaldo, Claudia Bighin, Giancarlo Bisagni, Valeria Forestieri, Francesco Cognetti - The Lancet 2015 cited by 201

  23. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

    Authors: Gianluigi Mancardi, Maria Pia Sormani, Massimo Di Gioia, Luisa Vuolo, Francesca Gualandi, Maria Pia Amato, Elisabetta Capello, Daniela Currò, Antonio Uccelli, Antonio Bertolotto, Claudio Gasperini, Alessandra Lugaresi, E. Merelli, G. Meucci, L. Motti, MR Tola, Elio Scarpini, A. Repice, Luca Massacesi, Riccardo Saccardi, the Italian BMT Study Group, Irene Donnini, Alberto Bosi, S. Guidi, A Bagigalupo, Laura Bonzano, Paolo Bruzzi, Luca Roccatagliata, R Antenucci, Franco Granella, Gianvito Martino, M. R. Rottoli, Claudio Solaro, Flavia Salvi, Alessandro Barilaro, Marco Capobianco - Multiple Sclerosis Journal 2011 cited by 135

  24. ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK FACTORS USING CASE-CONTROL DATA

    Authors: Paolo Bruzzi, Sylvan B. Green, David P. Byar, Louise A. Brinton, Catherine Schairer - American Journal of Epidemiology 1985 cited by 1,242